Imaging innovator Fonar, which calls itself “the most experienced MR manufacturer in the business,” has joined forces with Viatronix to spin off in a slightly different direction. It will market and sell the Stony Brook, NY, company’s CT
Imaging innovator Fonar, which calls itself the most experienced MR manufacturer in the business, has joined forces with Viatronix to spin off in a slightly different direction. It will market and sell the Stony Brook, NY, companys CT image processing and viewing products.
The announcement was made by Melville, NY-based Fonar, which has signed a letter of intent to enter into an agreement with Viatronix. Viatronix products, specifically the Viatron 2000 image capture and processing system and the Viatron 1000 viewer, enable clinicians to perform virtual colonoscopies and other procedures using CT.
Although CT is not Fonars primary area of expertise, the move is a logical one for the 22-year-old firm. The company may eventually form a joint venture with Viatronix aimed at determining how its technology might best be applied to MRI scanners.
The incomparable soft-tissue visualization that only MRI provides would be highly compatible with this wonderful technology and would be particularly compatible with Fonars array of open, high-speed MRI products, Dr. Raymond Damadian, president of the company, said in a news release. I also believe this combination of technologies would go a long way to halting the ravages of cancer.
The first Viatronix system is scheduled to be installed in Fonars MRI scanning center in Garden City, NY, Viatronix said. Other Fonar imaging centers that have both MRI and CT capabilities will install the technology later, according to Arie Kaufman, vice president of research and development for Viatronix and a codeveloper of the technology.
Fonar refused to specifically discuss the agreement with SCAN. However, in a news release the company said Viatronix technology holds significant potential.
The public has been highly resistant to the discomfort and associated risks of traditional optical colonoscopiesproblems that Viatronixs new product totally eliminates, said Timothy Damadian, president and CEO of Health Management Corp. of America, Fonars physician and diagnostic services subsidiary. Were especially enthusiastic because noninvasive colon screening is a perfect product for our diagnostic imaging centers.
The technology was developed at nearby State University of New York, Stony Brook, Kaufman said. Using volume-rendering technology developed by Viatronix, the Viatron 200 subtracts other body organs from the scan data and creates a real-time 3-D view of the colon. That model enables physicians to easily search the colon for polyps and other abnormalities.
Although the technologys most prominent application involves the colon, other uses are expected to follow. Those may include whole-body scans, scans of other organs, and imaging to detect aortic aneurysms. Aortic aneurysm is among the leading causes of death in the U.S.
Our products connect to any CT machine made by any manufacturer, Kaufman said. This is going to become the procedure of choice. Its been estimated that if compliance is similar to that of mammography, the gastroenterologists will be swampedthere will not be enough manpower to actually remove all the polyps that are found.
According to the American Cancer Society, some 56,600 deaths from colon cancer were reported during 1999. An estimated 129,400 new cases were diagnosed during the same period.
It is widely known that colorectal cancer is preventable with timely and accurate colon screening and subsequent removal of certain potentially dangerous polyps. Medical research indicates that a polyp may not grow to a life-threatening size for up to 10 years.
Will the technique eventually replace traditional colonoscopy, an uncomfortable procedure that involves insertion of an imaging device into the rectum?
This definitely has several advantages, Kaufman said. Its noninvasive, its comfortable, its accurate, its inexpensive, and its very fastin 40 seconds youre out. But, its primarily a mass screening procedure.
The cost of a CT colonoscopy is about $300, Kaufman said. By contrast, a traditional colonoscopy can range from $1000 to more than $2000.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.